FrancophonIA/ELRC3.0 huggingface dataset:
English: In study VI, improvement was observed at 12 months in abatacept plus methotrexate group as compared with the methotrexate plus placebo group in both PCS and MCS, and was maintained through 2 years.
Danish: I studie VI observeredes en forbedring efter 12 måneder i abatacept plus methotrexat-gruppen sammenlignet med methotrexat plus placebo-gruppen i både PCS og MCS, og forbedringen blev opretholdt gennem 2 år.
English: If your injection is administered by a caregiver, this person must also handle the Pen carefully to prevent accidental needle stick injury and possibly spreading infection.
Danish: Hvis du får injektionen af en omsorgsperson, skal vedkommende også håndtere pennen med forsigtighed for at undgå skader med kanylestik og muligvis spredning af infektion.
English: Discard any unused solution.
Danish: Kasser eventuel ubrugt opløsning.
English: What you need to know before you use ORENCIA
Danish: Det skal du vide, før du begynder at bruge ORENCIA
English: Don't touch the plunger while you remove the needle cover.
Danish: Undgå at røre stemplet, mens du fjerner kanylehætten.
English: Let your Pre-filled syringe warm up.
Danish: Lad din fyldte injektionssprøjte varme op.
English: Postmarketing reports of systemic injection reactions (e.g. pruritus, throat tightness, dyspnea) have been received following the use of subcutaneous ORENCIA.
Danish: Efter markedsføring er der rapporteret om systemiske injektionsreaktioner (f.eks. pruritus, sammensnøring i halsen, dyspepsi) efter anvendelse af subkutan ORENCIA.
English: Have the syringe ready for use immediately after you have prepared your injection site.
Danish: Injektionssprøjten skal være gjort klar, så du kan tage indsprøjtningen straks efter, du har klargjort injektionsstedet.
English: For children and adolescents aged 6 to 17 years with polyarticular juvenile idiopathic arthritis who weigh less than 75 kg, the recommended dose of intravenous abatacept is 10 mg/kg.
Danish: Til børn og unge i alderen 6-17 år med børnegigt, som vejer under 75 kg, er den anbefalede dosis 10 mg intravenøs abatacept/kg.
English: In studies I, II, and V the efficacy and safety of abatacept compared to placebo were assessed in patients with an inadequate response to methotrexate and who continued on their stable dose of methotrexate.
Danish: I studie I, II og V sammenlignedes effekt og sikkerhed af abatacept med placebo hos patienter, der havde utilstrækkeligt respons på methotrexat, og som fortsatte med stabil methotrexatdosis.
English: Summary of the safety profile in rheumatoid arthritis
Danish: Oversigt over sikkerhedsprofilen ved reumatoid artritis
English: Information on the relative safety in a clinical trial versus infliximab is summarised in section 5.1.
Danish: Oplysninger vedrørende relativ sikkerhed i et klinisk studie versus infliximab opsummeres i pkt.
English: Reconstitution of vials: under aseptic conditions, reconstitute each vial with 10 mL of water for injections, using the silicone-free disposable syringe provided with each vial and an 18-21 gauge needle.
Danish: Rekonstituering af hætteglas: rekonstituér hvert hætteglas aseptisk med 10 ml vand til injektionsvæsker ved hjælp af den silikonefrie engangssprøjte, der leveres med hvert hætteglas og en 18-21 gauge nål.
English: The recommended weekly dose of ORENCIA solution for injection in pre-filled syringe for patients 2 to 17 years of age with polyarticular juvenile idiopathic arthritis should be initiated without an intravenous loading dose and administered utilizing the weight range-based dosing as specified in the table below:
Danish: Den anbefalede ugentlige dosis af ORENCIA, injektionsvæske, opløsning, i fyldt injektionssprøjte til patienter i alderen 2 til 17 år med polyartikulær juvenil idiopatisk artritis bør initieres uden en intravenøs støddosis og administreres ved at benytte tabellen med dosering baseret på vægt-intervaller vist nedenfor:
English: If a patient misses an injection of ORENCIA and is within three days of the planned date, he/she should be instructed to take the missed dose immediately and remain on the original weekly schedule.
Danish: Hvis en patient har glemt en injektion med ORENCIA, og der ikke er gået mere end tre dage siden den planlagte dato, bør han/hun informeres om straks at tage den glemte dosis og holde sig til det oprindelige ugentlige skema.
English: Dose-dependent reductions were observed with abatacept in serum levels of soluble interleukin2 receptor, a marker of T lymphocyte activation; serum interleukin-6, a product of activated synovial macrophages and fibroblast-like synoviocytes in rheumatoid arthritis; rheumatoid factor, an autoantibody produced by plasma cells; and C-reactive protein, an acute phase reactant of inflammation.
Danish: Med abatacept sås der dosisafhængige fald i serumniveauer af opløselig interleukin-2-receptor, en markør for T-lymfocytaktivering; serum interleukin-6 (et produkt af aktiverede synovia-makrofager og fibroblast-lignende synoviocytter i reumatoid artritis); reumatoid faktor (et autoantistof dannet af plasmaceller) samt C-reaktivt protein (en akutfase-reaktant for inflammation).
English: Higher ACR 20 responses were observed with abatacept vs placebo regardless of prior TNF-inhibitor treatment in both studies.
Danish: Der blev observeret højere ACR-respons med abatacept vs. placebo uafhængig af tidligere behandling med TNF-hæmmer i begge studier.
English: Upon withdrawal of abatacept subcutaneous treatment, the increased rate of immunogenicity was consistent with that seen upon discontinuation of abatacept administered intravenously.
Danish: Efter seponering af subkutan abatacept-behandling var den øgede forekomst af immunogenicitet den samme som efter seponering af intravenøs abatacept-behandling.
English: ORENCIA selectively modulates the activation of T cells involved in the immune system's inflammatory response.
Danish: ORENCIA ændrer selektivt aktiveringen af de T-celler, der er involveret, når immunsystemet reagerer på betændelsesreaktioner.
English: After reconstitution, each mL contains 25 mg of abatacept.
Danish: Efter rekonstituering indeholder hver ml 25 mg abatacept.
English: At baseline 79% of 219 patients enrolled and treated in the study were taking methotrexate (mean dose at study entry, 12.3 mg/m2/week) and 21% of patients received abatacept monotherapy.
Danish: Ved baseline fik 79% af 219 rekrutterede og behandlede patienter methotrexat (gennemsnitlig dosis ved studiets start, 12,3 mg/m2/uge) og 21% af patienterne fik abatacept monoterapi.
English: In study VI, the efficacy and safety of abatacept were assessed in methotrexate-naive, Rheumatoid Factor (RF) and/or anti-Cyclic Citrullinated Peptide 2 (Anti-CCP2)-positive patients with early, erosive rheumatoid arthritis (≤ 2 years disease duration) who were randomised to receive abatacept plus methotrexate or methotrexate plus placebo.
Danish: I studie VI blev virkningen og sikkerheden af abatacept vurderet hos methotrexat-naive, reumatoidfaktor (RF)- og / eller cyklisk citrullineret peptid-antistof 2 (Anti-CCP2)-positive patienter med tidlig, erosiv reumatoid artritis (≤ 2 år sygdomsvarighed), som blev randomiseret til at få abatacept plus methotrexat eller methotrexat plus placebo.
English: If a patient misses an injection of abatacept and is within three days of the planned date, he/she should be instructed to take the missed dose immediately and remain on the original weekly schedule.
Danish: Hvis en patient har glemt en injektion med abatacept, og der ikke er gået mere end tre dage siden den planlagte dato, bør han/hun informeres om straks at tage den glemte dosis og holde sig til det oprindelige ugentlige skema.
English: From a 100 mL infusion bag or bottle, withdraw a volume of 0.9% sodium chloride injection equal to the volume of the reconstituted ORENCIA vials.
Danish: Fra en 100 ml infusionspose eller -flaske med 0,9% natriumchlorid injektionsvæske udtrækkes et volumen svarende til volumen i de rekonstituerede Orencia-hætteglas.
English: At 24 months, 20.8 % (66/318) of patients on abatacept and 25.3 % (83/328) on adalimumab had discontinued.
Danish: Ved 24 måneder havde 20,8 % (66/318) af patienterne i abatacept-gruppen og 25,3 % (83/328) af patienterne i adalimumab-gruppen seponeret behandlingen.
English: In rats and rabbits, abatacept exposure was up to 29-fold a human 10 mg/kg exposure based on AUC.
Danish: Hos rotter og kaniner var optagelsen af abatacept på op til 29 gange den humane dosis på 10 mg/kg, baseret på AUC.
English: In study PsA-II following weekly subcutaneous administration of abatacept at 125 mg, steady-state of abatacept was reached at day 57 with the geometric mean (CV%) cmin ranging from 22.3 (54.2%) to 25.6 (47.7%) mcg/mL on days 57 to 169, respectively.
Danish: I studie PsA-II efter ugentlig subkutan administration af abatacept 125 mg blev steady state for abatacept opnået på dag 57 med en geometrisk middelværdi (CV%) Cmin som rangerede fra 22,3 (54,2%) til 25,6 (47,7%) mikrog/ml på henholdsvis dag 57 til 169.
English: Do not give the injection in any areas with scars or stretch marks.
Danish: Du må ikke indsprøjte i et område med ar eller strækmærker.
English: More than 100 kg
Danish: Over 100 kg
English: Slight bleeding is normal.
Danish: Det er helt normalt, at det bløder lidt.
English: For instructions on reconstitution and dilution of the medicinal product before administration, see section 6.6.
Danish: For instruktioner om rekonstitution og fortynding af lægemidlet inden administration, se pkt.
English: Injection reactions
Danish: Injektionsreaktioner
English: Possible serious side effects include serious infections, malignancies (cancer) and allergic reactions, as listed below.
Danish: Alvorlige bivirkninger er anført nedenfor og omfatter alvorlige infektioner, kræft og overfølsomhedsreaktioner.
English: Patients who had not achieved at least a 20% improvement from baseline in their swollen and tender joint counts by Week 16 escaped to open-label abatacept 125 mg subcutaneous weekly.
Danish: Patienterne som ikke havde opnået mindst 20% forbedring fra baseline i deres hævede og ømme led ved uge 16 overgik til åben abatacept 125 mg subkutant ugentligt.
English: Insert the needle Gently insert the needle into the pinched skin at a 45º angle.
Danish: Indsæt kanylen Indsæt forsigtigt kanylen i den fastklemte hud i en vinkel på 45º.
English: The presence of antibodies was not associated with adverse reactions, or with changes in efficacy or serum abatacept concentrations, in either cohort.
Danish: Tilstedeværelsen af antistoffer var ikke forbundet med bivirkninger eller med ændring i virkning eller serum-abataceptkoncentrationer i nogen af aldersgrupperne.
English: This medicinal product contains 0.014 mmol sodium (0.322 mg) per pre-filled pen, that is to say essentially ‘sodium- free'.
Danish: Dette lægemiddel indeholder 0,014 mmol (0,322 mg) natrium per fyldt pen, dvs. det er i det væsentlige natriumfrit.
English: In study VI, the mean change in TSS at 12 months was significantly lower in patients treated with abatacept plus methotrexate compared to those treated with methotrexate plus placebo.
Danish: I studie VI var den gennemsnitlige ændring i TSS efter 12 måneder signifikant lavere hos patienter behandlet med abatacept plus methotrexat sammenlignet med patienter behandlet med methotrexat plus placebo.
English: Do not use this medicine if you notice opaque particles, discolouration or other foreign particles present in the infusion solution.
Danish: Brug ikke dette lægemiddel, hvis du bemærker uigennemsigtige partikler, misfarvning eller andre fremmedlegemer i infusionsvæsken.
English: When the reconstituted solution is diluted immediately, the chemical and physical in-use stability of the diluted infusion solution has been demonstrated for 24 hours at 2°C - 8°C.
Danish: Når den rekonstituerede infusionsvæske fortyndes straks, er der vist kemisk og fysisk holdbarhed af den fortyndede infusionsvæske i 24 timer ved 2°C - 8°C.
English: Don't throw away used syringes in your household rubbish or recycling bins.
Danish: Læg ikke brugte injektionssprøjter i dit husholdningsaffald eller skraldespand.
English: You will find detailed instructions for the preparation and administration of ORENCIA at the end of this leaflet (see "Important instructions for use").
Danish: Du kan se en detaljeret instruktion om klargøring og indgivelse af ORENCIA sidst i denne indlægsseddel (se ”Vigtig brugervejledning”).
English: In pre-clinical embryo-fetal development studies no undesirable effects were observed at doses up to 29-fold a human 10 mg/kg dose based on AUC.
Danish: Der er i prækliniske embryo-føtale udviklingsstudier ikke observeret uønskede hændelser ved doser på op til 29 gange den humane dosis på 10 mg/kg, baseret på AUC.
English: When reconstitution and dilution are performed under aseptic conditions ORENCIA infusion solution can be used immediately or within 24 hours if stored refrigerated at 2°C to 8°C.
Danish: Når rekonstituering og fortynding er udført under aseptiske forhold, kan ORENCIAinfusionsvæsken anvendes straks eller inden for 24 timer, såfremt den opbevares i køleskab ved 2°C - 8°C.
English: During the open-label periods of studies I, II, III, and VI the improvement in physical function has been maintained through 7 years, 5 years, 5 years, and 2 years, respectively.
Danish: I de åbneperioder i studie I, II, III og VI var forbedring i fysisk funktion opretholdt gennem henholdsvis 7 år, 5 år, 5 år og 2 år.
English: Abatacept has been studied in patients with active rheumatoid arthritis in placebo-controlled clinical trials (2,653 patients with abatacept, 1,485 with placebo).
Danish: Abatacept er undersøgt hos patienter med aktiv reumatoid artritis i placebo-kontrollerede, kliniske studier (2.653 patienter behandlet med abatacept, 1.485 behandlet med placebo).
English: During the 24-month cumulative period of the pJIA SC study (4-month short term period plus 20-month extension period), a higher frequency of infections was reported in the 2 to 5 year age cohort (87.0%) compared to that reported in the 6 to 17 year age cohort (68.2%).
Danish: Under den 24 måneder lange kumulative periode i pJIA s.c.-studiet (den kortvarige periode på 4 måneder plus forlængelsesperioden på 20 måneder) blev der indberettet en højere hyppighed af infektioner i aldersgruppen 2-5 år (87,0%) sammenlignet med den der blev indberettet i aldersgruppen 6-17 år (68,2%).
English: Listed in Table 1 are adverse reactions observed in clinical trials and post-marketing experience presented by system organ class and frequency, using the following categories: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000).
Danish: Tabel 1 angiver bivirkninger observeret i kliniske undersøgelser og efter markedsføring opdelt i organklasse og hyppighed i følgende kategorier: Meget almindelig (≥ 1/10); Almindelig (≥ 1/100 til < 1/10); Ikke almindelige (≥ 1/1.000 til < 1/100); Sjælden (≥ 1/10.000 til < 1/1.000); Meget sjælden (< 1/10.000).
English: the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who responded inadequately to previous therapy with one or more disease-modifying anti-rheumatic drugs (DMARDs) including methotrexate (MTX) or a tumour necrosis factor (TNF)-alpha inhibitor.
Danish: behandling af moderat til svær, aktiv reumatoid artritis (RA) hos voksne patienter, som har haft utilstrækkeligt respons på tidligere behandling med et eller flere sygdomsmodificerende antireumatiske lægemidler (DMARDs) inklusive methotrexat (MTX) eller en tumornekrosefaktor (TNF)-alfa-hæmmer.
English: During the 12-month treatment period, adverse reactions were reported in 44.5% (53/119), 41.4% (48/116), and 44.0% (51/116) and serious adverse reactions were reported in 2.5% (3/119), 2.6% (3/116) and 0.9% (1/116) of patients treated in the three treatment groups, respectively.
Danish: I løbet af den 12 måneder lange behandlingsperiode blev der rapporteret bivirkninger hos henholdsvis 44,5% (53/119), 41,4% (48/116) og 44,0% (51/116) og alvorlige bivirkninger hos 2,5% (3/119), 2,6% (3/116) og 0,9% (1/116) af patienterne i de tre behandlingsgrupper.
English: Determine the dose and the number of ORENCIA vials needed (see section 4.2).
Danish: Beregn dosis og det antal ORENCIA-hætteglas, der er behov for (se pkt.
English: Listed in Table 2 are adverse reactions observed in clinical trials and post-marketing experience presented by system organ class and frequency, using the following categories: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000).
Danish: Tabel 2 angiver bivirkninger observeret i kliniske undersøgelser og efter markedsføring opdelt i organklasse og hyppighed i følgende kategorier: Meget almindelig (≥ 1/10); Almindelig (≥ 1/100 til < 1/10); Ikke almindelige (≥ 1/1.000 til < 1/100); Sjælden (≥ 1/10.000 til < 1/1.000); Meget sjælden (< 1/10.000).
English: Antibodies directed against the entire abatacept molecule or to the CTLA-4 portion of abatacept were assessed by ELISA assays in patients with pJIA following repeated treatment with intravenous ORENCIA.
Danish: Antistoffer rettet mod hele abatacept-molekylet eller mod CTLA-4 delen af abatacept blev vurderet ved ELISA-metoden hos patienter med pJIA efter gentagen behandling med intravenøs ORENCIA.
English: - Do not use the vial if the vacuum is not present.
Danish: - Brug ikke hætteglasset, hvis der ikke er vakuum.
English: In a pre- and postnatal development study in rats, limited changes in immune function were observed at 11-fold higher than a human 10 mg/kg dose based on AUC (see section 5.3).
Danish: Der er i et præ- og postnatalt udviklingsstudie hos rotter observeret begrænsede forandringer i immunfunktionen ved en dosis 11 gange højere end den humane dosis på 10 mg/kg, baseret på AUC (se pkt.
English: Allergic reactions have been reported uncommonly with abatacept administration in clinical trials, where patients were not required to be pretreated to prevent allergic reactions (see section 4.8).
Danish: Der er i sjældne tilfælde rapporteret allergiske reaktioner med abatacept i kliniske studier , der ikke var omfattet af krav om, at patienterne skulle modtage forbehandling til forebyggelse af allergiske reaktioner (se pkt.
English: DO NOT RECAP the pre-filled syringe at any time, as this may damage, bend, or break the needle.
Danish: SÆT IKKE HÆTTEN tilbage på den fyldte injektionssprøjte på noget tidspunkt, da det kan beskadige, bøje eller ødelægge kanylen.
English: Needle Cover (ORANGE Cap)
Danish: Kanylehætte (ORANGE hætte)
English: The geometric mean (CV%) cmin at day 169 were 7.8 mcg/mL (56.3%) for the 3/3 mg/kg, 24.3 mcg/mL (40.8%) for 10/10 mg/kg, and 26.6 mcg/mL (39.0%) for the 30/10 mg/kg regimens.
Danish: Den geometriske middelværdi (CV%) Cmin ved dag 169 var 7,8 mikrog/ml (56,3%) for 3/3 mg/kg, 24,3 mikrog/ml (40,8%) for 10/10 mg/kg og 26,6 mikrog/ml (39,0%) for 30/10 mg/kg behandlingsregimet.
English: In the cumulative period 7,044 patients treated with abatacept during 21,011 patient-years (of which over 1,000 were treated with abatacept for over 5 years), the incidence rate of malignancy was 1.2 (1.1, 1.4) per 100 patient-years, and the annualized incidence rates remained stable.
Danish: I den samlede periode med 7.044 abatacept-behandlede patienter gennem 21.011 patientår (hvoraf flere end 1.000 blev behandlet med abatacept i mere end 5 år) var incidensraten for malignitet 1,2 (1,1, 1,4) pr. 100 patientår, og de årlige incidensrater forblev stabile.
English: *(e.g. pruritus, throat tightness, dyspnea)
Danish: * (f.eks. pruritus, sammensnøring i halsen, dyspepsi)
English: One hundred and two (67%) of the subjects had received at least 1,080 days (~ 36 months) of abatacept therapy in Period C. All patients had at least 4 months of prior, open-label abatacept treatment in Period A.
Danish: Ethundrede og to (67%) forsøgspersoner fik abataceptbehandling i mindst 1.080 dage (~ 36 måneder) i periode C. Alle patienter havde tidligere fået mindst 4 måneders åben behandling med abatacept i periode A.
English: Common (may affect up to 1 in 10 people): upper airway infection (including infections of nose, sinus and throat) fever
Danish: Almindelige (kan påvirke op til 1 ud af 10 personer): øvre luftvejsinfektioner (inklusive infektion af næse, bihule og hals) feber
English: If you miss your dose by more than three days, ask your doctor when to take your next dose.
Danish: Hvis der er gået mere end tre dage siden den planlagte dato, skal du spørge lægen, hvornår du skal tage den næste dosis.
English: Summary of the safety profile in psoriatic arthritis
Danish: Oversigt over sikkerhedsprofilen ved psoriasisartritis
English: No dose adjustment is required (see section 4.4).
Danish: Dosisjustering ikke nødvendig (se pkt.
English: Tell your doctor as soon as possible if you notice any of the following: feeling generally unwell, dental problems, burning sensation during urination, painful skin rash, painful skin blisters, coughing
Danish: Kontakt lægen så hurtigt som muligt, hvis du bemærker følgende: generel utilpashed, tandproblemer, brændende fornemmelse, når du lader vandet, smertefuldt udslæt, smertefulde blærer på huden, hoste.
English: In the 2 to 5 year age cohort, the overall rate of seropositivity during the cumulative period including post abatacept follow-up was 15.2% (7/46): 10.9% (5/46) on treatment and 37.5% (3/8) after discontinuation of abatacept (≥ 28 days after the last dose).
Danish: I aldersgruppen 2-5 år var den samlede forekomst af seropositivitet under den kumulative periode inklusive opfølgning efter abatacept 15,2% (7/46): 10.9% (5/46) under behandlingen og 37,5% (3/8) efter seponering af abatacept (≥ 28 dage efter sidste dosis).
English: Abatacept therapy did not lead to increased formation of autoantibodies, i.e., antinuclear and antidsDNA antibodies, compared with placebo.
Danish: Abataceptbehandling medførte ikke øget dannelse af autoantistoffer dvs. antinukleære og anti-dsDNAantistoffer, sammenlignet med placebo.
English: Don't press on the plunger head until you begin your injection.
Danish: Du må ikke trykke på stempelhovedet, før du begynder indsprøjtningen.
English: Therefore, concurrent therapy with abatacept and a TNF-inhibitor is not recommended.
Danish: Samtidig behandling med abatacept og en TNF-hæmmer frarådes derfor.
English: Greater improvement (p < 0.001) in DAS28 was observed with abatacept and with infliximab compared to placebo at six months in the placebo-controlled portion of the trial; the results between the abatacept and infliximab groups were similar.
Danish: Der sås større forbedring i DAS28 (p < 0,001) med abatacept og med infliximab sammenlignet med placebo ved 6 måneder i den placebokontrollerede del af studiet.
English: In study SC-III, structural joint damage was assessed by MRI.
Danish: I studie SC-III vurderedes strukturel ledskade ved MR-scanning.
English: In study VI, statistically significant improvement in the ACR 20 response in abatacept plus methotrexate-treated patients versus methotrexate plus placebo-treated patients was observed at 29 days, and was maintained through the duration of the study.
Danish: I studie VI observeredes en statistisk signifikant forbedring i ACR 20-respons hos abatacept plus methotrexat-behandlede patienter versus methotrexat plus placebo-behandlede patienter på dag 29, og forbedringen blev opretholdt gennem hele studiet.
English: Hold the syringe by its body in one hand, and pull the needle cover straight off with your other hand (Figure 4).
Danish: Hold injektionssprøjten på cylinderen med den ene hånd og træk kanylehætten af uden at dreje/vippe den med den anden hånd (Figur 4).
English: The abatacept + MTX group had less progression in structural damage compared with MTX group as reflected by mean treatment difference of the abatacept + MTX group versus MTX group (Table 6).
Danish: I abatacept + MTX-gruppen sås mindre progression i strukturel ledskade sammenlignet med MTX-gruppen, udtrykt som gennemsnitlig behandlingsforskel i abatacept + MTX-gruppen versus MTX-gruppen (Tabel 6).